ReviewThe Canadian journal of urology2026
Clear cell sarcoma of the kidney with inferior vena cava tumor thrombus in a pediatric patient: a case report.
Review in The Canadian journal of urology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
backgroundClear cell sarcoma of the kidney (CCSK) is a rare and highly aggressive pediatric renal malignancy with a marked propensity for metastatic spread. Cases of CCSK associated with inferior vena cava (IVC) tumor thrombus (IVCTT) are exceptionally uncommon in the literature. We report a case of CCSK with IVCTT in a 15-month-old male infant. CASE DESCRIPTION: We reported a case admitted in May 2020 for a 3-day history of fever and hematuria. Abdominal CT revealed an unevenly enhanced mass and low-density shadows within the IVC. The diagnosis of CCSK was confirmed via needle biopsy. The patient received 4 cycles of adjuvant chemotherapy. The initial surgery lasted 10 h with 600 mL blood loss, and primary closure was achieved. Postoperative management included 6 cycles of radiotherapy and 5 cycles of chemotherapy. In March 2022, CT detected IVCTT recurrence, requiring surgical intervention involving thrombus removal and partial IVC resection. This procedure lasted 8 h with 300 mL blood loss, followed by 5 additional chemotherapy cycles. The patient showed no sign of IVC obstruction, including varicose veins or lower limb edema, and maintained renal function throughout follow-up. However, Intracranial metastases were detected 15 months postoperatively. After the family opted against additional treatment, the patient succumbed to the disease.
conclusionsThe management of CCSK associated with IVCTT should include consideration of IVC thrombectomy. In case of recurrent IVCTT with preserved collateral circulation, combined thrombus excision and partial IVC resection may be warranted.
Indexed as
Identifiers
41800516What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.